AMGN (amgen.com) יחס שווי שוק לשווי בספרים

The market-to-book ratio of Amgen Inc. (AMGN) demonstrates the resilience of this biotech behemoth focused on oncology and rare disease therapies. The value 20.85 serves as the current reading of this metric. Surplus cash flow ensures reliable coverage of loan obligations. The expansion of scientific potential is driven by licensing deals and the integration of innovative laboratories.

This indicator determines the premium of a business's market value over its net assets, allowing for an assessment of the overpayment for the company's capital. By analyzing the current price-to-book multiple trend, an investor can see the balance between the value of Amgen Inc. (AMGN) biologics and its balance sheet assets, where stable income from the integration of acquisitions confirms the validity of the market valuation prior to the launch of new growth catalysts.